Business

PURE Bioscience to Present at the B. Riley & Co. 18th Annual Investor Conference

PURE Bioscience to Present at the B. Riley & Co. 18th Annual Investor Conference.

articlePure BioscienceMay 11, 20174/company/pure-bioscience-inc/news/pure-bioscience-to-present-at-the-b-riley-and-co-18th-annual-investor-conference
PURE Bioscience to Present at the B. Riley & Co. 18th Annual Investor Conference

About this update from Pure Bioscience

[{"type":"text","content":"\n \n PURE Bioscience, Inc. (OTCQB: \n PURE), creator of the patented non-toxic silver \n dihydrogen citrate (SDC) \n antimicrobial, today announced that the Company will present at the B. \n Riley & Co. 18th Annual Investor Conference on May 25, \n 2017, at the Lowes Santa Monica Hotel in Santa Monica, CA.\n \n \n Hank \n R. Lambert, CEO of PURE, will present at 10:00am PDT and provide \n business updates on the Company’s two food safety antimicrobials:\n \n \n \n PURE® Hard Surface disinfectant\n\n \n \n Recent sales to Chipotle Mexican Grill and other restaurants, and \n expanding use with +40 national food processors\n \n \n Presently +$2 million annualized revenue run rate\n \n \n \n \n PURE Control® (FDA approved direct food contact processing aid)\n\n \n \n Sales & marketing to fresh produce processors; first order \n received in April\n \n \n Progress of USDA in-plant trials for approval for raw poultry \n processing\n \n \n SDC test results demonstrate materially significant reduction in Salmonella, \n Listeria and E. coli contamination in fresh produce; \n and dramatic reduction of Salmonella contamination in raw \n poultry.\n \n \n Est. combined +$650 million U.S. market opportunity for produce \n and poultry processing aids\n \n \n \n \n \n The presentation will be webcast live with slides (and available for \n replay) and can be accessed at: http://www.wsw.com/webcast/brileyco18/pure.\n \n \n About B. Riley & Co., LLC\n \n \n B. Riley & Co., LLC is a leading investment bank providing advisory, \n research, and sales & trading to corporate, institutional and high net \n worth individual clients. Investment banking services include M&A \n advisory and debt and equity offerings. The firm is nationally \n recognized for its highly ranked proprietary equity research. B. Riley & \n Co. is a member of FINRA and SIPC. For more information, please visit www.brileyco.com.\n \n \n About PURE Bioscience, Inc.\n \n \n PURE Bioscience, Inc. is focused on developing and commercializing our \n proprietary antimicrobial products primarily in the food safety arena – \n providing solutions to the health and environmental challenges of \n pathogen and hygienic control. Our technology platform is based on \n patented stabilized ionic silver, and our initial products contain \n silver dih...

More updates from Pure Bioscience